About Acarix AB 
Acarix AB
Pharmaceuticals & Biotechnology
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Company Coordinates 
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Dr. Werner Braun
Chairman of the Board
Dr. Claus Andersson
Director
Mr. Yun Fei Hong
Director
Mr. Ulf Rosen
Director
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-13 Million
Pharmaceuticals & Biotechnology
SEK 305 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.63
-136.25%
7.92






